What if the cause of cancer is lurking in your kitchen? A startling study, funded by the United States government, suggests that cooking oils may be a significant factor in the rise of cancer, particularly among younger individuals. This research, published in the medical journal Gut, examined the effects of excessive consumption of seed oils, including sunflower, grapeseed, canola, and corn oils, and their correlation with an elevated cancer risk.

Findings of the study:

The research involved 80 patients diagnosed with colon cancer. It was found that these individuals exhibited elevated levels of bioactive lipids, which are produced through the breakdown of seed oils. Additionally, an analysis of 81 tumor samples from patients aged 30 to 85 revealed that the high lipid content in their cancerous tumors was linked to the consumption of seed oils.

Seed oils are a relatively recent addition to the food industry. In the early 1900s, candle-maker William Procter developed seed oils as a cost-effective substitute for animal fats in soap production. However, they quickly became a dietary staple for many Americans.

Seed oil and its association with cancer: An overview

Previous research has investigated the detrimental effects of seed oil on health, particularly its potential to induce inflammation within the body. The breakdown of these bioactive lipids may accelerate the development of colon cancer and hinder the body's ability to combat tumors. Seed oils are rich in omega-6 and polyunsaturated fatty acids, and ongoing studies aim to clarify their relationship with diabetes and cardiovascular diseases. Additionally, it is noted that omega-3 fatty acids derived from fish are more effective than those from flaxseed in cancer prevention.

The research paper indicates that chronic inflammation resulting from excessive consumption of seed oils can promote the growth and advancement of cancer. “Our findings reveal that the lipidomic profile of colorectal cancer tumors displays a pronounced pro-inflammatory tendency, coupled with a lack of endogenous resolving mediators due to impaired lipid class switching. These insights open avenues for ‘resolution medicine,’ a pioneering therapeutic strategy aimed at introducing or supplying resolvins to alleviate the chronic inflammation that fuels cancer growth and progression,” states an excerpt from the study.

Read Also: Lose 10 kg in 3 Months: Simple Healthy Swaps from a Fitness Coach